Effect of Combining Traditional Chinese Medicine with Hormonal Therapy on Quality of Life and Tumor Markers of Prostate Cancer Patients

Table 2

Analysis of patients’ general information (n = 30).

Observation indicator	Control group	Experimental group	X^2/t
Age (years)	57.42 ± 6.38	58.04 ± 6.40	0.376	0.708
KPS score	64.02 ± 6.04	63.77 ± 6.12	0.159	0.874
FACT-P score	69.84 ± 6.65	70.15 ± 6.83	0.178	0.859
Duration of disease (months)	12.51 ± 2.56	12.84 ± 2.67	0.489	0.627
Number of chemotherapy (times)	8.05 ± 1.72	8.17 ± 1.69	0.273	0.786
Prostate volume (ml)	71.86 ± 3.28	71.93 ± 3.35	0.082	0.935
Gleason score	8.25 ± 1.17	8.34 ± 1.26	0.287	0.775
TNM stage
II	11 (36.67)	9 (30)	0.300	0.584
III	18 (60)	19 (63.33)	0.071	0.791
IV	1 (3.33)	2 (6.67)	0.351	0.554
Pathological examination
Good differentiation	7 (23.33)	8 (26.67)	0.089	0.766
Poor differentiation	16 (53.33)	17 (56.67)	0.067	0.795
No differentiation	7 (23.33)	5 (16.67)	0.417	0.519
CEA (μg/L)	11 (36.67)	9 (30)	0.376	0.708
NSE (μg/L)	18 (60)	19 (63.33)	0.159	0.874
CYFRA21-1 (μg/L)	1 (3.33)	2 (6.67)	0.178	0.859